Treatment with low-dose interferon-α restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder

Clinical Cancer Research

Volumn 7, Issue 9, 2001, Pages 2840-2853

  Slaton, Joel W ^a   Karashima, Takashi ^a,b   Perrotte, Paul ^a   Inoue, Keiji ^a,b   Kim, Sun J ^a   Izawa, Jonathan ^a   Kedar, Daniel ^a   McConkey, David J ^a   Millikan, Randall ^a   Sweeney, Paul ^a   Yoshikawa, Chiaki ^b   Shuin, Taro ^b   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GELATINASE B; PACLITAXEL; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY; BLOOD VESSELS; BLOTTING, NORTHERN; CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL MOVEMENT; COLLAGEN; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; INTERFERON-ALPHA; INTERLEUKIN-8; LAMININ; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; PROGNOSIS; PROTEOGLYCANS; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034808422     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Cancer statistics
2. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion
3. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy
4. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
5. Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: A Phase II trial of the Eastern Cooperative Oncology Group
6. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
7. Molecular determinants of angiogenesis in cancer metastasis
8. Angiogenic molecules and cancer metastasis
9. Tumor invasion and metastasis-role of extracellular matrix: Rhoads Memorial Award Lecture
10. Neutral metalloproteinases produced by human mononuclear phagocytes: Enzyme profile, regulation, and expression during cellular development
11. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinoma
12. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells
13. Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade
14. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency
15. Increased incidence of matrix metalloproteinases in urine of cancer patients
16. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloporteinase-2 expression in bladder cancer
17. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer
18. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma
19. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer
20. Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection
21. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion
22. Dominant role of E-cadherin in the progression of bladder cancer
23. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder
24. Expression of E-cadherin and α-, β-, and γ-catenins in human bladder carcinoma: Are they good prognostic factors?
25. Cell adhesion molecules in bladder cancer: Soluble serum E-cadherin correlates with predictors of recurrence
26. E-cadherin expression in bladder cancer using formalin-fixed paraffin-embedded tissues: Correlation with histopathological grade, tumour stage and survival
27. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer following neoadjuvant chemotherapy and radical cystectomy
28. Virus interference.I. The interferon
29. The interferons: A biological system with therapeutic potential in viral infections
30. Role of interferons in the regulation of cell proliferation, differentiation, and development
31. Cytokine therapeutics: Lessons from interferon-α. Proc. Natl. Acad. Sci. USA
32. Interferons in malignancy: Biological products or biological response modifies?
33. Effects of interferons and other cytokines on tumors in animals: A review
34. Cell density-dependent modulation of basic fibroblast growth factor expression by human interferon-β
35. Down-regulation of interleukin-8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition of interferon
36. Interferon-β prevents the upregulation of interleukin-8 expression in human melanoma cells
37. Human recombinant interferons β and α decrease gelatinase production by human KG-2 renal carcinoma cells
38. Modulation of the invasive phenotype of human colon carcinoma cells by fibroblasts from orthotopic or ectopic organs of nude mice
39. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon-β
40. Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-α
41. Antiproliferative activity of interferon α and retinoic acid in SiHa carcinoma cells: The role of cell adhesion
42. Cytokines and thyroid epithelial integrity: Interleukin-1α induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes
43. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic intefferon-α administration
44. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice
45. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
46. Molecular cloning and characterization of the human E-cadherin cDNA
47. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells
48. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells
49. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas
50. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice
51. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells
52. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
53. Wild-type p53 regulates its own transcription in a cell-type specific manner
54. A new in vitro assay for quantitating tumor cell invasion
55. Complete one-hour immunocytochemistry based on capillary action
56. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
57. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
58. Regression modelslife tables
59. Cadherin cell adhesion receptors as a morphogenetic regulator
60. Cadherins: A molecular family important in selective cell-cell adhesion
61. Cadherin cell-adhesion molecules in human epithelial tissues and carcinoma
62. Expression of E- and P-cadherin in gastric carcinomas
63. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
64. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
65. Metalloproteinases and cancer invasion
66. Matrix metalloproteinases: Multifunctional contributors to tumor progression
67. Matrix metalloproteinases: Biologic activity and clinical implications
68. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
69. Regulation of cell invasion and morphogenesis and in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
70. Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma
71. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line
72. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
73. Different angiogenic pathways characterize superficial and invasive bladder cancer
74. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rate
75. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma
76. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinoma
77. Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinoma
78. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma
79. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma
80. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers
81. Interferon-α and survival in renal cell carcinoma
82. The role of interferon α in the treatment of metastatic melanoma
83. 5-Flurouracil and interferon-α in chemotherapy refractory bladder carcinoma: An effective regimen
84. Evaluation of low dose α-interferon (Roferon-A) in patients with advanced renal cell carcinoma: Southwest Oncology Group study
85. Interferon α-2b adjuvant therapy of high risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
86. Recombinant human interleukin-2, recombinant human interferon α-2a, or both in metastatic renal-cell carcinoma
87. Antitumor effects of interferon
88. Kaposi's sarcoma and AIDS treatment with high and low doses of recombinant leukocyte A interferon
89. Interferon α-2a therapy for life-threatening hemangiomas of infancy
90. Treatment of pulmonary hemangiomatosis with recombinant interferon-a-2a
91. The interferons. Mechanisms of action and clinical applications
92. Transcriptional induction of two genes in human cells by b interferon
93. o/G arrest. Nature (Lond.)
94. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells
95. Interferon treatments: How to use an endogenous system as a therapeutic agent
96. Interferon-α-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
97. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines
98. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression
99. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
100. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis
101. Disruption of cell-cell adhesion in the presence of sodium butyrate activates expression of the 92 kDa type IV collagenase in MDCK cells
102. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1